Evaluate the scientific foundations, development risks, and clinical plausibility to surface strengths and potential liabilities of technologies.

Compare portfolio or target companies across maturity, technology fit, and evidence readiness to guide capital allocation.

Quantify addressable markets, assess growth trends, and benchmark competitive landscapes to validate investment hypotheses.

Develop valuation models under multiple outcome scenarios, from regulatory delays to rapid adoption, to stress-test potential returns.

Analyze reimbursement regimes, payer incentives, and other regulatory constraints to anticipate access and adoption risks.

Engage with portfolio companies to refine execution plans: evidence strategy, go-to-market pathways, and access tactics.